leisure time -WSS

leisure time

author：explore 2025-09-30 12:17:18 - browse：13454

A cloud with a medical folder on the top of an illustration is connected to other medical vectors such as a doctor on a phone screen, a health watch, and a brain chip — coverage from STAT — Adobe

Federal health technology regulators on Wednesday finalized new rules to force software vendors to disclose how artificial intelligence tools are trained, developed, and tested — a move to protect patients against biased and harmful decisions about their care.

The rules are aimed at placing guardrails around a new generation of AI models gaining rapid adoption in hospitals and clinics around the country. These tools are meant to help predict health risks and emergent medical problems, but little is publicly known about their effectiveness, reliability, or fairness.

Starting in 2025, electronic health record vendors who develop or supply these tools, which increasingly use a type of AI known as machine learning, will be required to disclose more technical information to clinical users about their performance and testing, as well as the steps taken to manage potential risks.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Telehealth options flood the market as retailers push virtual care

knowledge

focus

WSS

FDA approves updated Covid vaccines

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

First Opinion Podcast: How to protect health care in times of war

Medtronic CEO on promising devices for diabetes, hypertension

WATCH: Why do bright lights make us see spots?

Diversifying clinical trials isn't enough to close racial gaps: study

focus

leisure time

hotspot

Virginia high school admissions case could be legal follow

FDA has safety concerns on CRISPR

State Dept. review finds Biden bears some blame for Afghanistan failures

Telehealth options flood the market as retailers push virtual care

Alkermes shareholders re

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Duchenne breakthrough therapy leaves behind pioneering families

Generate Biomedicines machine learning biotech raises $273M

entertainment

Biden's order seeks to regulate AI risk without stifling innovation

Readout Newsletter: New research from Sanofi, Regeneron, etc.

FDA approves updated Covid vaccines

Why Sanofi got shellacked over its spinoff

Generate Biomedicines machine learning biotech raises $273M

Readout Newsletter: New research from Sanofi, Regeneron, etc.

knowledge

focus

entertainment

hotspot